HUMANIZED ANTI-C5 ANTIBODIES AND FACTOR H FUSION PROTEINS AND USES THEREOF

摘要

Provided is inhibition of the complement signaling using an anti-C5 antibody or fusion protein thereof. Specifically, provided are methods of treating a complement-mediated disease or complement-mediated disorder in an individual by contacting the individual with an anti-C5 antibody fusion protein thereof.